HK75889A - Parenteral formulation of nimodipin, process for its preparation and its therapeutical use - Google Patents

Parenteral formulation of nimodipin, process for its preparation and its therapeutical use

Info

Publication number
HK75889A
HK75889A HK758/89A HK75889A HK75889A HK 75889 A HK75889 A HK 75889A HK 758/89 A HK758/89 A HK 758/89A HK 75889 A HK75889 A HK 75889A HK 75889 A HK75889 A HK 75889A
Authority
HK
Hong Kong
Prior art keywords
weight
per cent
parts
nimodipine
ethanol
Prior art date
Application number
HK758/89A
Other languages
German (de)
English (en)
French (fr)
Inventor
Dieter Dr. Hoff
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HK75889A publication Critical patent/HK75889A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
HK758/89A 1983-05-06 1989-09-21 Parenteral formulation of nimodipin, process for its preparation and its therapeutical use HK75889A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833316510 DE3316510A1 (de) 1983-05-06 1983-05-06 Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen

Publications (1)

Publication Number Publication Date
HK75889A true HK75889A (en) 1989-09-29

Family

ID=6198265

Family Applications (1)

Application Number Title Priority Date Filing Date
HK758/89A HK75889A (en) 1983-05-06 1989-09-21 Parenteral formulation of nimodipin, process for its preparation and its therapeutical use

Country Status (19)

Country Link
US (1) US5114956A (da)
EP (1) EP0126315B1 (da)
JP (1) JPS59206305A (da)
KR (1) KR920000306B1 (da)
AT (1) ATE24835T1 (da)
AU (1) AU562293B2 (da)
BE (1) BE899564A (da)
CA (1) CA1220424A (da)
DE (2) DE3316510A1 (da)
DK (1) DK164148C (da)
ES (1) ES531995A0 (da)
FR (1) FR2545354B1 (da)
GR (1) GR81609B (da)
HK (1) HK75889A (da)
IL (1) IL71744A (da)
IT (1) IT1181804B (da)
PT (1) PT78542B (da)
SG (1) SG44489G (da)
ZA (1) ZA843352B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
AT387518B (de) * 1985-12-18 1989-02-10 Bayer Ag Verfahren zur herstellung von fluessigen spruehpraeparaten von dihydropyridinen
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
DE3702105A1 (de) * 1987-01-24 1988-08-04 Bayer Ag Parenterale loesung
CA2011063C (en) * 1989-02-28 1999-07-06 Calum B. Macfarlane Nicardipine pharmaceutical composition for parenteral administration
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
WO1996019233A2 (en) * 1994-12-12 1996-06-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
BR9509985A (pt) 1995-12-12 1998-11-03 Omeros Med Sys Inc Solução para irrigação e método para inibição de dor inflamação e esparmo
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
US8034762B2 (en) * 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
WO2007047406A2 (en) * 2005-10-14 2007-04-26 Transform Pharmaceuticals, Inc. Liquid pharmaceutical compositions of nimodipine
EP2015730A1 (de) * 2006-04-28 2009-01-21 Basf Se Verfahren zur solubilisierung von hydrophoben wirkstoffen in wässrigem medium
WO2011095449A1 (de) 2010-02-05 2011-08-11 Basf Se Verfahren zur solubilisierung von hydrophoben wirkstoffen in wässrigem medium
US8728504B2 (en) 2010-02-05 2014-05-20 Basf Se Process for solubilizing hydrophobic active ingredients in aqueous medium
CN103635179B (zh) 2011-04-28 2017-12-29 普拉福姆五金器具第二有限公司 亲脂性药剂的改进的胃肠外制剂以及制备和使用其的方法
BR112018070960A2 (pt) 2016-04-13 2019-01-29 Nortic Holdings Inc. formulação parenteral de nimodipina estável
US10092553B2 (en) 2016-04-13 2018-10-09 Nortic Holdings Inc. Stable nimodipine parenteral formulation
JP2021513995A (ja) 2018-02-22 2021-06-03 ノーティック ホールディングス インコーポレイテッド 安定したニモジピン非経口製剤
JP2025517753A (ja) 2022-05-16 2025-06-10 アカスティ ファーマ ユー．エス．，インコーポレイテッド ニモジピン非経口投与
CN117502433A (zh) * 2023-11-08 2024-02-06 中国科学院海洋研究所 一种水母刺丝囊存放保护剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2650013C3 (de) * 1976-10-30 1981-04-02 Bayer Ag, 5090 Leverkusen 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
AU562293B2 (en) 1987-06-04
IL71744A (en) 1988-04-29
DK224184D0 (da) 1984-05-04
GR81609B (da) 1984-12-11
US5114956A (en) 1992-05-19
ZA843352B (en) 1984-12-24
DK164148C (da) 1992-10-26
KR840009031A (ko) 1984-12-24
IT8448139A0 (it) 1984-05-04
FR2545354A1 (fr) 1984-11-09
DK164148B (da) 1992-05-18
JPS59206305A (ja) 1984-11-22
ES8505542A1 (es) 1985-06-01
JPH0422888B2 (da) 1992-04-20
IL71744A0 (en) 1984-09-30
CA1220424A (en) 1987-04-14
DE3461988D1 (en) 1987-02-19
FR2545354B1 (fr) 1986-09-26
AU2758384A (en) 1984-11-08
IT8448139A1 (it) 1985-11-04
KR920000306B1 (ko) 1992-01-11
ATE24835T1 (de) 1987-01-15
DE3316510A1 (de) 1984-11-08
BE899564A (fr) 1984-11-05
PT78542B (en) 1986-07-14
IT1181804B (it) 1987-09-30
ES531995A0 (es) 1985-06-01
EP0126315B1 (de) 1987-01-14
SG44489G (en) 1989-11-17
PT78542A (en) 1984-06-01
EP0126315A1 (de) 1984-11-28
DK224184A (da) 1984-11-07

Similar Documents

Publication Publication Date Title
KR920000306B1 (ko) 니모디핀-함유 제제의 제조방법
DE69233169T2 (de) Cisplatin und Topotecan enthaltende Zusammensetzung als antitumor.
DE68910138T2 (de) Fumagillin als angiostatisches Mittel.
DE69713485T2 (de) Medikamente für die Behandlung oder Vorbeugung von Thrombocytopenie
LU84546A1 (de) Verwendung von peptiden als medikamente
BG65417B1 (bg) Приложение на еритропоетин или еритропоетинови производни за лечение на мозъчни исхемии
Petersen et al. Chronic pain treatment with intravenous lidocaine
EP0249873B1 (en) Therapeutic agent for skin ulcers
EP0166183B1 (de) Verwendung von Hydroxyindolderivaten zur Herstellung eines Arzneimittels zur Senkung des Blutdrucks
Osborn et al. Single-dose oral phenytoin loading
US3852453A (en) Method of enhancing vincamine compositions
JPH03135918A (ja) 免疫賦活剤
US3906107A (en) Aminoalkyl sulfate esters with diuretic activity
US4829068A (en) Treatment of disorders of the gastro-intestinal tract
US4335128A (en) Process for the treatment of patients suffering from drepanocytosis
DE69422496T2 (de) Mittel gegen malaria
DE68912159T2 (de) Dioxoquinazolinderivat enthaltendes Antihypertensivum.
US3764675A (en) Method of treatment of cardiac bradyarrhythmias
DE3821392A1 (de) Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on (ebselen)
DE3626868A1 (de) Parenterale loesung
US3961064A (en) Pharmaceutical composition for remedy of hyperammoniemia
EP4603081A1 (en) An injectable composition of brivaracetam
EP0273253A2 (de) Verwendung von 6-Allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[5,4-d]azepin zur Freisetzung von Wachstumshormon
DE68905178T2 (de) Stabile waessrige zubereitung von aktivem vitamin-d-3.
KR19990022036A (ko) 방사선 장해의 치료방법

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20040423

PE Patent expired